112 related articles for article (PubMed ID: 11436153)
1. The role of immunohistochemistry in the differential diagnosis of serous effusions.
Cangi MG; Pecciarini L; Doglioni C
Adv Clin Path; 2000 Oct; 4(4):183-5. PubMed ID: 11436153
[No Abstract] [Full Text] [Related]
2. Mesothelioma: diagnostic immunohistochemical markers.
Chilosi M
Adv Clin Path; 2000 Oct; 4(4):179-83. PubMed ID: 11436152
[No Abstract] [Full Text] [Related]
3. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: a follow-up and comparative investigation.
Jensen ML; Johansen P
Diagn Cytopathol; 1996 Jul; 15(1):33-6. PubMed ID: 8807249
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the c-Met immunostain to detect malignant cells in body cavity effusions.
Zimmerman RL; Fogt F
Oncol Rep; 2001; 8(6):1347-50. PubMed ID: 11605063
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4 in mesothelioma diagnosis.
Facchetti F; Gentili F; Lonardi S; Bercich L; Santin A
Histopathology; 2007 Aug; 51(2):261-3. PubMed ID: 17573941
[No Abstract] [Full Text] [Related]
7. Hyaluronic acid in serous effusion smears.
Whitaker D
Acta Cytol; 1986; 30(1):90-1. PubMed ID: 3456192
[No Abstract] [Full Text] [Related]
8. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
9. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
10. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas.
Georgescu CV; Florescu M; Simionescu C
Rom J Morphol Embryol; 1999-2004; 45():133-42. PubMed ID: 15847387
[TBL] [Abstract][Full Text] [Related]
11. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
12. [Studies on "lace" cells in effusions of serous cavity (author's transl)].
Liu SF
Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):11-3. PubMed ID: 7094798
[No Abstract] [Full Text] [Related]
13. [Structure and functional pathology concerning cytology of body cavities].
Hackl H
Med Welt; 1980 Aug; 31(34):1197-201. PubMed ID: 7432122
[No Abstract] [Full Text] [Related]
14. [Clinico-diagnostic role of examination of exudates and transudates].
Kuklina MA; Martsishevskaia RL
Lab Delo; 1982; (11):691-5. PubMed ID: 6184539
[No Abstract] [Full Text] [Related]
15. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
16. The role of immunohistochemistry in differentiating between peritoneal mesothelioma and ovarian serous carcinoma.
Al-Rawi HJ; Ben-Ghashir NS
Saudi Med J; 2009 Apr; 30(4):571-4. PubMed ID: 19370292
[No Abstract] [Full Text] [Related]
17. [Structure and function of the serous membrane--with special reference to mesothelial cells].
Kamei T; Uchino F
Rinsho Byori; 1990 Nov; Suppl 87():1-16. PubMed ID: 1704935
[No Abstract] [Full Text] [Related]
18. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
[TBL] [Abstract][Full Text] [Related]
19. [Cytologic studies of the exudates of serous cavities].
Sarkisian LM
Zh Eksp Klin Med; 1969; 9(5):103-5. PubMed ID: 5376343
[No Abstract] [Full Text] [Related]
20. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
